MedWatch

Foto: Spar Nord/PR

Orphazyme cuts guidance following FDA setback

Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.

Olympus hires former Ambu CEO

Japanese medtech company Olympus has hired the former long-time Ambu executive Lars Marcher as a new advisor to the firm, which recently launched a portfolio of single-use bronchoscopes which could give Ambu a run for their money.

Foto: Yves Herman/REUTERS / X00380

EMA to be beefed up for future crises

The European Council wishes to reinforce EU preparedness for potential future health emergencies. The Danish Association of the Pharmaceutical Industry supports this idea.

Novo Holdings plans to enter China

Following three investments via the newly-established Singapore office, Novo Holdings is poised to expand its Asian venture to China, where it hopes to open an office before the end of the year.

Latest news

See all jobs